RGS 0.00% 12.0¢ regeneus ltd

Ann: Chinese patent granted on stem cell secretions technology, page-3

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 76 Posts.
    lightbulb Created with Sketch. 5
    RGS may not communicate as often as other listed companies, but they surely stick to their strategy with purpose and determination.
    In 2009, they started the journey on MSC secretions for acute skin inflammation with a topical cream for dogs. It really worked in reducing skin inflammation. They then worked on developing a proprietary technology around MSCs secretions and they have now secured a patent for the largest market on the planet for acne.
    They are so much closer to product development than most of us realise...
    Well executed plan!
 
watchlist Created with Sketch. Add RGS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.